Capricor Therapeutics Current Cash

Capricor Therapeutics (CAPR) currently reports a current cash of $110M as of March 2026. That compares with $29B in the prior-year period — down 99.6% year over year. Use the charts on this page to explore Capricor Therapeutics's current cash history and peer comparisons.

Capricor Therapeutics's current cash decreased from $29B to $110M — a 99.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Capricor Therapeutics reported $110M in current cash as of March 2026. That compares with $29B in the prior-year period — down 99.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Capricor Therapeutics, and consider following CAPR for alerts when major investors trade the stock.

Capricor Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CAPR with unrelated industries.